Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | ABBV:NYQ since announced | Transaction value |
---|---|---|
Cerevel Therapeutics Holdings Inc | 10.40% | 8.62bn |
ImmunoGen Inc | 15.24% | 10.22bn |
Data delayed at least 15 minutes, as of May 23 2024 00:00 BST.
Holder | Shares | % Held |
---|---|---|
Caixa DTVM SAas of 31 Jan 2024 | 414.95k | 0.00% |
BB Gest�o de Recursos DTVM SAas of 31 Jan 2024 | 216.10k | 0.00% |
Bram Bradesco Asset Management S/A DTVMas of 31 Jan 2024 | 61.52k | 0.00% |
XP Allocation Asset Management Ltda.as of 31 Jan 2024 | 1.90k | 0.00% |
More ▼
Data from 31 Jan 2024 - 16 May 2024Source: FactSet Research Systems Inc.